Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Obesity Medicine
•
Primary Care
How do you decide whether to reinitiate a GLP-1 agonist after a patient has experienced acute pancreatitis while on this therapy?
Answer from: at Community Practice
Will not try it again, given the seriousness of the side effect, and in most cases, there are alternatives.
Sign In
or
Register
to read more
27578
Related Questions
How do you discuss the role (if there is any) of frequently weighing yourself at home for patients who desire weight loss?
Do you recommend restarting GLP-1RA after bariatric surgery if they tolerated it before the surgery?
Do you avoid the use of GLP-1 R agonist therapy for treatment of obesity in patients with known gastroparesis?
How do you discuss the importance of ongoing lifestyle-based interventions when starting a GLP-1 agonist for medically relevant obesity (i.e., with comorbid conditions)?
What strategies do you recommend to address the negative self-talk/internalized bias that patients carry about their own weight?
How do you decide which GLP-1s to prescribe for obesity?
How do you counsel patients who want to use vaping to quit smoking cigarettes?
Do you prefer a specific clinical scoring system to determine if a patient needs to be tested for Group A Streptococcal pharyngitis?
How do you approach the choice of pharmacological therapy when treating insomnia in older adults in the outpatient setting with a high falling risk?
What are some practical ways to incorporate cardiac POCUS in the primary care setting?